Kantonsspital Liestal   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Liestal Switzerland (2012)

Organization Overview

First Clinical Trial
2012
NCT00392691
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Kantonsspital Liestal

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Lymphoma (Phase 1)

Pneumonia (Phase 3)

Staphylococcal Infections (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 8